Title | : | MULTI-PARAMETER LEAD OPTIMIZATION TO GIVE AN ORAL CHK1 INHIBITOR CLINICAL CANDIDATE: (R)-5-((4-((MORPHOLIN-2-YLMETHYL)AMINO)-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)AMINO)PYRAZINE-2-CARBONITRILE (CCT245737)
|
| |
Authors | : | I. Collins, M. D. Garrett, R. Van Montfort, J. D. Osborne, T. P. Matthew T. Mchardy, N. Proisy, K. J. Cheung, M. Lainchbury, N. Brown, M. I. Walt P. D. Eve, K. J. Boxall, A. Hayes, A. T. Henley, M. R. Valenti, A. K. De Ha Brandon, G. Box, I. M. Westwood, Y. Jamin, S. P. Robinson, P. Leonard, J. C. Reader, G. W. Aherne, F. I. Raynaud, S. A. Eccles |
Date | : | 03 Dec 15 (Deposition) - 25 May 16 (Release) - 22 Jun 16 (Revision) |
Method | : | X-RAY DIFFRACTION |
Resolution | : | 1.91 |
Chains | : | Asym./Biol. Unit : A |
Keywords | : | Inhibitor Dna-Damage Chk1-Potency Herg-Activity, Transferase (Keyword Search: [Gene Ontology, PubMed, Web (Google)] ) |
| |
Reference | : | J. D. Osborne, T. P. Matthews, T. Mchardy, N. Proisy, K. M. Cheung, M. Lainchbury, N. Brown, M. I. Walton, P. D. Eve, K. J. Boxall, A. Hayes, A. T. Henley, M. R. Valenti, A. K. De Haven Brandon, G. Box, Y. Jamin, S. P. Robinson, I. M. Westwood, R. L. Van Montfort, P. M. Leonard, M. B. Lamers, J. C. Reader, G. W. Aherne, F. I. Raynaud, S. A. Eccles, M. D. Garrett, I. Collins Multiparameter Lead Optimization To Give An Oral Checkpoint Kinase 1 (Chk1) Inhibitor Clinical Candidate: (R)-5-((4-((Morpholin-2-Ylmethyl)Amino)-5-(Trifluoromethyl) Pyridin-2-Yl)Amino)Pyrazine-2-Carbonitrile (Cct245737). J. Med. Chem. V. 59 5221 2016 |
|